CEO’s Tax‑Driven Sale of 10,000+ Revelation Shares Holds Steady Market Price【Flash】
CEO Rolke James sells 10,115 Revelation Biosciences shares at market price—tax‑plan, not a confidence signal. Focus on pipeline, not insider trades.
3 minutes to read